DiaCarta partners with OncoAssure for prostate cancer test commercialization

[News]

DiaCarta, Inc., a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in California, today announced that it has established a strategic collaboration with OncoAssure Ltd, an Irish medical diagnostics company headquartered at NovaUCD in Dublin.

More... (https://www.news-medical.net/news/20240227/DiaCarta-partners-with-OncoAssure-for-prostate-cancer-test-commercialization.aspx)